Michael Stillabower
Cardiovascular Disease · Newark, DENPI 1548237472
Payments from drug & device makers
What this record shows
Merit Medical Systems Inc accounts for 61.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2019 at $3,621 and has fallen 99.5% since, to $18 in 2022.
Across 95 payments — averaging $40.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merit Medical Systems Inc$2K
- AstraZeneca$382
- Amgen$211
- Boehringer Ingelheim$144
- Amarin Pharma, Inc.$123
- Sanofi-aventis U.S. LLC$113
- plus $504 from 11 others
Across 2 payments — averaging $11,997 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amarin Pharma, Inc.$24K
What the payments were for
- Travel & lodging$2,26559%
- Food & beverage$1,56841%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merit Medical Systems Inc | 12 | $2,357 |
| AstraZeneca | 19 | $382 |
| Amgen | 13 | $211 |
| Boehringer Ingelheim | 8 | $144 |
| Amarin Pharma, Inc. | 8 | $123 |
| Sanofi-aventis U.S. LLC | 7 | $113 |
| Novartis | 7 | $109 |
| Johnson & Johnson | 7 | $107 |
| Preventice Services, LLC | 1 | $99 |
| Regeneron Healthcare Solutions, Inc. | 3 | $39 |
| E.r. Squibb & Sons, L.L.C. | 3 | $37 |
| Alnylam Pharmaceuticals Inc. | 2 | $30 |
| Portola Pharmaceuticals, LLC | 1 | $22 |
| Boston Scientific | 1 | $18 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $15 |
| Pfizer | 1 | $14 |
| W. L. Gore & Associates, Inc. | 1 | $14 |
How this compares
$3,833 in reported general payments places this provider in the 60th percentile of 104 cardiovascular disease providers in Delaware.
Other cardiovascular disease in Newark
- Edward GoldenbergNewark$52K
- Muhammad ShakirNewark$47K
- Anthony AlfieriNewark$45K
- Sean DikdanNewark$42K
- Kirk GarrattNewark$38K
- Anthony ClayNewark$37K
- Ashish ParikhNewark$26K
- William WeintraubNewark$24K
- Wen Chi TsaiNewark$20K
- Stephen MengNewark$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.